These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16475242)

  • 1. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
    Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
    J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.
    Adusumilli PS; Chan MK; Chun YS; Hezel M; Chou TC; Rusch VW; Fong Y
    Cancer Biol Ther; 2006 Jan; 5(1):48-53. PubMed ID: 16294031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.
    Stiles BM; Adusumilli PS; Bhargava A; Stanziale SF; Kim TH; Chan MK; Huq R; Wong R; Rusch VW; Fong Y
    Cancer Gene Ther; 2006 Jan; 13(1):53-64. PubMed ID: 16037824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
    Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y
    Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
    Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
    Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma.
    Adusumilli PS; Chan MK; Hezel M; Yu Z; Stiles BM; Chou TC; Rusch VW; Fong Y
    Ann Surg Oncol; 2007 Jan; 14(1):258-69. PubMed ID: 17080237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.
    Harada A; Uchino J; Harada T; Nakagaki N; Hisasue J; Fujita M; Takayama K
    Cancer Sci; 2017 Jan; 108(1):116-123. PubMed ID: 27783867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.
    Bennett JJ; Delman KA; Burt BM; Mariotti A; Malhotra S; Zager J; Petrowsky H; Mastorides S; Federoff H; Fong Y
    Cancer Gene Ther; 2002 Nov; 9(11):935-45. PubMed ID: 12386832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
    Stiles BM; Bhargava A; Adusumilli PS; Stanziale SF; Kim TH; Rusch VW; Fong Y
    Surgery; 2003 Aug; 134(2):357-64. PubMed ID: 12947341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus.
    Adusumilli PS; Eisenberg DP; Stiles BM; Chung S; Chan MK; Rusch VW; Fong Y
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1179-88. PubMed ID: 17059941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer.
    Eisenberg DP; Adusumilli PS; Hendershott KJ; Yu Z; Mullerad M; Chan MK; Chou TC; Fong Y
    J Gastrointest Surg; 2005 Nov; 9(8):1068-77; discussion 1077-9. PubMed ID: 16269377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.
    Keshava S; Rao LV; Pendurthi UR
    Sci Rep; 2016 Nov; 6():36829. PubMed ID: 27833109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
    Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
    Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging.
    Adusumilli PS; Eisenberg DP; Stiles BM; Hendershott KJ; Stanziale SF; Chan MK; Hezel M; Huq R; Rusch VW; Fong Y
    Surg Endosc; 2006 Apr; 20(4):628-35. PubMed ID: 16446989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer.
    Stanziale SF; Stiles BM; Bhargava A; Kerns SA; Kalakonda N; Fong Y
    Hum Gene Ther; 2004 Jun; 15(6):609-18. PubMed ID: 15212719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.
    Silberhumer GR; Brader P; Wong J; Serganova IS; Gönen M; Gonzalez SJ; Blasberg R; Zamarin D; Fong Y
    Mol Cancer Ther; 2010 Oct; 9(10):2761-9. PubMed ID: 20858727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J; Hu P; Zeng M; Rabkin SD; Liu R
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.